Bloomberg Law named Hooper, Lundy & Bookman partner Nina Marsden to its 2021 “They’ve Got Next: Five Fresh Faces to Know in Healthcare and Life Sciences” series, which highlights the work of rising stars of the health care and life sciences bar.
Nina is a partner in the Los Angeles office and serves as Chair of the firm’s COVID-19 Task Force. Nina represents health care providers, including hospitals, pharmacies, and laboratories, with licensure and certification, regulatory compliance, operational issues, and ownership changes.
The Bloomberg article features Nina’s work throughout 2020’s COVID-19 lockdown “managing the change-of-ownership regulatory review process for a three-hospital health system in California, enabling the deal to close at year end as planned.”
Nina commented that managing the regulatory process for a this kind of deal is like “putting together a puzzle”. Katrina Pagonis, chair of Hooper, Lundy & Bookman’s regulatory practice said that, “very few other people could have done it” and that Nina’s knowledge of “byzantine” regulatory structures and agency contacts helped to delivered the desired results.